BIM for the pharmaceutical industry in Spain: how to reduce risks, timelines and interferences in Life Science projects

Spain has established itself as one of Europe’s leading pharmaceutical industrial hubs. Growth in production, a commitment to innovation and increased investment in new plants and R&D centres are driving a transformation of the sector, which requires increasingly technological, efficient facilities adapted to the most demanding regulatory standards.

In this context, the complexity of Life Science projects has increased significantly. The construction of a pharmaceutical plant no longer consists solely of delivering an industrial building, but of coordinating thousands of critical technical variables —from HVAC systems and pressure gradients to utility networks, laboratories and clean rooms— within highly regulated environments governed by GMP standards (Good Manufacturing Practices).

In this scenario, BIM for the pharmaceutical industry has become a key tool for reducing risks, optimising timelines and ensuring the reliability of facilities from the earliest stages of the project.

As an engineering company specialising in complex industrial projects, GSE Iberia integrates BIM methodology (Building Information Modeling) as a central part of its Design & Build model. Beyond 3D design, this methodology makes it possible to create a digital twin of the industrial building, integrating architecture, structure, installations and planning within a single collaborative environment.

The objective is clear: to identify issues before they arise on site and ensure greater efficiency throughout the entire lifecycle of the asset.

BIM for the pharmaceutical industry: preventing interferences and reducing risks

One of the main challenges in pharmaceutical construction is the high technical density of the projects. These buildings contain complex HVAC networks, technical pipework, production systems, laboratories and controlled-contamination areas, where any interference can lead to delays, critical modifications and cost overruns.

BIM methodology makes it possible to anticipate these issues through advanced clash detection systems, identifying collisions between disciplines before construction begins.

Thanks to this integrated planning, multidisciplinary teams can identify incompatibilities between structures, installations and technical equipment at an early stage, minimising changes during execution and facilitating a smoother and more controlled construction process.

Furthermore, in environments such as clean rooms or pharmaceutical laboratories —where the available technical space is very limited— BIM makes it possible to optimise volumes and improve accessibility for future maintenance operations, a fundamental aspect in ensuring regulatory compliance and long-term operability.

4D construction in Life Science projects

In the pharmaceutical industry, reducing execution times is a strategic factor. Every week saved in the commissioning of a new plant can have a direct impact on production capacity and the launch of new medicines onto the market.

For this reason, one of the main advantages of BIM applied to Life Science projects is the incorporation of so-called 4D construction, which adds the time factor to the digital model.

This methodology makes it possible to integrate the construction schedule into the BIM environment in order to simulate the evolution of the project and optimise each construction phase.

This makes it possible to:

• accurately coordinate the arrival of machinery and critical equipment;
• optimise site logistics;
• avoid bottlenecks;
  
  
• overlap activities safely and in a controlled manner.

All of this helps to reduce timelines and accelerate the Time-to-Market of new pharmaceutical facilities.

Virtual reality and Digital Twins in the pharmaceutical industry

Industrial digitalisation is driving new ways of designing and managing pharmaceutical facilities. Among them, virtual reality is becoming established as a key tool in projects involving a high level of technical complexity.

Through immersive environments and virtual models, engineering, operations and client teams can digitally walk through the future plant even before construction begins.

This makes it possible to:

• validate layouts;
• review personnel and material flows;
• optimise ergonomics and functionality;
• minimise the risks associated with late changes.

Furthermore, once the project has been completed, the BIM model evolves into an As-Built Digital Twin.

This complete digital representation facilitates:

• maintenance;
  facility management;
  future expansions;
  operational control and traceability.
• facility management;
  
  
• future expansions;
• operational control and traceability.

In a context where efficiency and traceability are critical, these tools help to protect the value of the industrial asset and improve its long-term performance.

GSE Iberia: BIM and digitalisation for complex pharmaceutical projects

The growing sophistication of the pharmaceutical industry in Spain is driving a new generation of projects in which precision, technical coordination and schedule control are essential.

In this context, working with a General Contractor specialising in BIM for the pharmaceutical industry makes it possible to achieve greater efficiency, control and anticipation throughout every stage of the project.

Examples include projects such as the platform developed for Fedefarma, designed to meet the highest standards in healthcare distribution. This type of facility shares critical requirements with the pharmaceutical environment: environmental control, traceability, operational efficiency and regulatory compliance.

Examples include projects such as the platform developed for Fedefarma, designed to meet the highest standards in healthcare distribution. This type of facility shares critical requirements with the pharmaceutical environment: environmental control, traceability, operational efficiency and regulatory compliance.

FAQ

What is BIM in the pharmaceutical industry?

It is a digital methodology that makes it possible to design, coordinate and manage pharmaceutical facilities through intelligent 3D models.

What advantages does BIM provide in Life Science projects?

It reduces interferences, optimises timelines, improves coordination and minimises construction risks.

What is a pharmaceutical Digital Twin?

It is a digital replica of the completed facility that facilitates maintenance and operational management.